ArticleFrontiers in medicine2026

Pregnancy outcomes of patients with retained products of conception following miscarriage treated with relugolix, an oral gonadotropin-releasing hormone antagonist.

Satoko Sasatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.